دورية أكاديمية

Impact of Hyperglycemia on Outcomes among Patients Receiving Neoadjuvant Chemotherapy for Bulky Early Stage Cervical Cancer.

التفاصيل البيبلوغرافية
العنوان: Impact of Hyperglycemia on Outcomes among Patients Receiving Neoadjuvant Chemotherapy for Bulky Early Stage Cervical Cancer.
المؤلفون: Jing Li, Miao-Fang Wu, Huai-Wu Lu, Bing-Zhong Zhang, Li-Juan Wang, Zhong-Qiu Lin
المصدر: PLoS ONE, Vol 11, Iss 11, p e0166612 (2016)
بيانات النشر: Public Library of Science (PLoS), 2016.
سنة النشر: 2016
المجموعة: LCC:Medicine
LCC:Science
مصطلحات موضوعية: Medicine, Science
الوصف: The impact of hyperglycemia on survival of patients undergoing neoadjuvant chemotherapy (NACT) for bulky early stage cervical cancer (BESCC) has not been explored.Records of patients who received NACT and radical hysterectomy in our institution between January 2005 and June 2010 were reviewed.In total, 347 patients were included. The median follow-up time was 37 months (range: 4-65). Patients with hyperglycemia (fasting blood glucose ≥ 100 mg/dl) had shorter recurrence-free survival (RFS) (univariate hazard ratio [HR] = 1.95, 95% confidence interval [CI] [1.16, 3.28], P = 0.010) and cancer-specific survival (CSS) (univariate HR = 2.24, 95% CI [1.33, 3.78], P = 0.002) compared with those with euglycemia (fasting blood glucose
نوع الوثيقة: article
وصف الملف: electronic resource
اللغة: English
تدمد: 1932-6203
Relation: http://europepmc.org/articles/PMC5113016?pdf=render; https://doaj.org/toc/1932-6203
DOI: 10.1371/journal.pone.0166612
URL الوصول: https://doaj.org/article/95fee731b3704227a4f46ee6434a0a60
رقم الأكسشن: edsdoj.95fee731b3704227a4f46ee6434a0a60
قاعدة البيانات: Directory of Open Access Journals
الوصف
تدمد:19326203
DOI:10.1371/journal.pone.0166612